Roche Holding AG (RHOA)
Munich
Closed
Sep 25, 2026
Day's Range
383.9452 wk Range
323.25Overview - RHOA - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
318.43B
P/E (Trailing)
‪20.98‬
Price / Sales (TTM)
‪4.59‬
Price / Book
‪7.92‬
EV / EBITDA
‪14.33‬
Profitability
Profit Margin
‪20.33%‬
Operating Margin
‪29.99%‬
Return on Assets
‪12.93%‬
Return on Equity
‪37.27%‬
Ownership
Shares Outstanding
796.76M
Float
726.03M
Held by Insiders
‪0.00%‬
Held by Institutions
‪42.02%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪369.58‬
200-Day Avg
‪324.41‬
Dividends
Payout Ratio
‪60.47%‬
Frequency
Annual
Market Cap - RHOA - Roche Holding AG
Peers - RHOA - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Munich.
- RHOAMunichRoche Holding AG290.82BMarket Cap-0.22%52-week change20.98P/E (Trailing)‪20.33%‬Profit Margin
- CUP0MunichChugai Pharmaceutical Co., Ltd.57.59BMarket Cap-18.86%52-week change21.88P/E (Trailing)‪35.10%‬Profit Margin
- ON4MunichOno Pharmaceutical Co. Ltd.6.31BMarket Cap+28.15%52-week change16.38P/E (Trailing)‪15.11%‬Profit Margin
- SZD0MunichSanten Pharmaceutical Co., Ltd.3.08BMarket Cap+3.13%52-week change15.24P/E (Trailing)‪13.25%‬Profit Margin
Profile Summary - RHOA - Roche Holding AG
About
Roche Holding AG is a Swiss healthcare holding company headquartered in Basel, overseeing one of the world’s largest integrated pharmaceuticals and diagnostics groups. The company operates today through two main divisions: Pharmaceuticals, which focuses on prescription medicines across oncology, immunology, infectious…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
